A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making.

Mauer J, Whichello C, Hauber B, Krucien N, Law EH, Trapali M, Senna M, Zwillich SH, Wolk R, Tervonen T

DOI: 10.1016/j.jval.2025.09.007
Published: 2026 Feb
Container: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jval.2025.09.007,
  title = {A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making.},
  author = {Mauer J and Whichello C and Hauber B and Krucien N and Law EH and Trapali M and Senna M and Zwillich SH and Wolk R and Tervonen T},
  year = {2026},
  journal = {Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  doi = {10.1016/j.jval.2025.09.007},
  url = {https://doi.org/10.1016/j.jval.2025.09.007}
}

RIS

TY  - JOUR
TI  - A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making.
AU  - Mauer J
AU  - Whichello C
AU  - Hauber B
AU  - Krucien N
AU  - Law EH
AU  - Trapali M
AU  - Senna M
AU  - Zwillich SH
AU  - Wolk R
AU  - Tervonen T
PY  - 2026
JO  - Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
DO  - 10.1016/j.jval.2025.09.007
UR  - https://doi.org/10.1016/j.jval.2025.09.007
ER  -

APA

J, M., C, W., B, H., N, K., EH, L., M, T., M, S., SH, Z., R, W., & T, T. (2026). A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. https://doi.org/10.1016/j.jval.2025.09.007

Source records

pubmed · retrieved 2026-09-25T13:08:47.170Z
europe-pmc · retrieved 2026-09-25T13:08:47.181Z